Cargando…
A Comprehensive Biomarker Analysis of Microsatellite Unstable/Mismatch Repair Deficient Colorectal Cancer Cohort Treated with Immunotherapy
The search for immunotherapy biomarkers in Microsatellite Instability High/Deficient Mismatch Repair system (MSI-H/dMMR) metastatic colorectal cancer (mCRC) is an unmet need. Sixteen patients with mCRC and MSI-H/dMMR (determined by either immunohistochemistry or polymerase chain reaction) treated wi...
Autores principales: | Élez, Elena, Mulet-Margalef, Núria, Sanso, Miriam, Ruiz-Pace, Fiorella, Mancuso, Francesco M., Comas, Raquel, Ros, Javier, Argilés, Guillem, Martini, Giulia, Sanz-Garcia, Enrique, Baraibar, Iosune, Salvà, Francesc, Noguerido, Alba, Cuadra-Urteaga, Jose Luis, Fasani, Roberta, Garcia, Ariadna, Jimenez, Jose, Aguilar, Susana, Landolfi, Stefania, Hernández-Losa, Javier, Braña, Irene, Nuciforo, Paolo, Dienstmann, Rodrigo, Tabernero, Josep, Salazar, Ramon, Vivancos, Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820517/ https://www.ncbi.nlm.nih.gov/pubmed/36613564 http://dx.doi.org/10.3390/ijms24010118 |
Ejemplares similares
-
Molecular subtypes and the evolution of treatment management in metastatic colorectal cancer
por: Martini, Giulia, et al.
Publicado: (2020) -
BRAF, MEK and EGFR inhibition as treatment strategies in BRAF V600E metastatic colorectal cancer
por: Ros, Javier, et al.
Publicado: (2021) -
The impact of clinical and translational research on the quality of life during the metastatic colorectal cancer patient journey
por: Rodriguez Castells, Marta, et al.
Publicado: (2023) -
Encorafenib plus cetuximab for the treatment of
BRAF-V600E-mutated metastatic colorectal
cancer
por: Ros, Javier, et al.
Publicado: (2022) -
Impact of the COVID-19 pandemic in the early-onset colorectal cancer
por: Baraibar, Iosune, et al.
Publicado: (2023)